MARKET

AZN

AZN

AstraZeneca
NYSE
188.42
+5.02
+2.74%
After Hours: 189.05 +0.63 +0.33% 19:40 03/27 EDT
OPEN
190.88
PREV CLOSE
183.40
HIGH
192.97
LOW
187.95
VOLUME
2.76M
TURNOVER
--
52 WEEK HIGH
210.50
52 WEEK LOW
122.08
MARKET CAP
292.23B
P/E (TTM)
28.78
1D
5D
1M
3M
1Y
5Y
1D
Morning News Wrap-Up: 3/27/26: Today’s Biggest Stock Market Stories
TipRanks · 1d ago
AstraZeneca Study Sheds Light on Real‑World Risks in Biliary Tract Cancer Care
TipRanks · 1d ago
Midday Fly By: Carnival cuts forecast on fuel cost, Novartis to buy Excellergy
TipRanks · 1d ago
J.P. Morgan Keeps Their Buy Rating on AstraZeneca (AZN)
TipRanks · 1d ago
HLTH, ESIH, HLT: Look to Europe for Healthcare ETFs
TipRanks · 1d ago
Barclays Reaffirms Their Buy Rating on AstraZeneca (AZN)
TipRanks · 1d ago
Morning Movers: AstraZeneca jumps following tozorakimab trial results
TipRanks · 1d ago
De‑Risking a Multibillion-Dollar COPD Opportunity: Buy Rating on AstraZeneca Following Strong Tozorakimab Phase III Data
TipRanks · 1d ago
More
About AZN
AstraZeneca PLC is a United Kingdom-based science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines. The Company operates across therapy areas, including Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory and Immunology (R&I); Vaccines and Immune Therapies (V&I), and Rare Disease. In the Oncology area, its key products include Tagrisso, Imfinzi, Calquence, Lynparza, and Enhertu. The key products of CVRM area include Farxiga/Forxiga, Brilinta/Brilique, Crestor, and Lokelma. In the R&I area, the key products are Symbicort, Fasenra, Breztri/Trixeo, and Tezspire. In the V&I Therapies area, the products are Beyfortus and FluMist. The products in the Rare Disease area are Ultomiris, Soliris, Strensiq, and Koselugo. It has about 191 projects in its development pipeline, including 19 new molecular entities (NMEs) in the late-stage pipeline. The Company distributes its products in over 125 countries.

Webull offers AstraZeneca PLC (US) stock information, including NYSE: AZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZN stock methods without spending real money on the virtual paper trading platform.